News Genetic deficiency of NOD2 confers resistance to invasive aspergillosis

10 July 2018

Frank van de Veerdonk, theme Infectious diseases and global health, and colleagues, demonstrate in Nature Communications, that genetic deficiency of NOD2 plays a protective role during Aspergillus infection.

Publication: link.

Invasive aspergillosis (IA) is a severe infection that can occur in severely immunocompromised patients. Efficient immune recognition of Aspergillus is crucial to protect against infection, and previous studies suggested a role for NOD2 in this process. However, thorough investigation of the impact of NOD2 on susceptibility to aspergillosis were lacking. Common genetic variations in NOD2 have been associated with Crohn's disease and now Van de Veerdonk and colleagues, investigated the influence of these genetic variations on the anti-Aspergillus host response. A NOD2 polymorphism reduced the risk of IA after hematopoietic stem-cell transplantation. Mechanistically, absence of NOD2 in monocytes and macrophages increases phagocytosis leading to enhanced fungal killing. Conversely, NOD2 activation reduces the antifungal potential of these cells. Crucially, Nod2 deficiency results in resistance to Aspergillus infection in an in vivo model of pulmonary aspergillosis. Collectively, these data demonstrate that genetic deficiency of NOD2 plays a protective role during Aspergillus infection.

Related news items


Christine Mohrmann stipendium for Karlien Mul

14 December 2018

The goal of the stipendium is to enable junior female scientists to perform research abroad and to encourage them to pursue a scientific career in academia.

read more

Call for nominations RIHS Awards 2017 & 2018

14 December 2018

RIHS researchers are invited to propose candidates for the RIHS PhD Award, the Societal Impact Award, the Science Award and the Supervisor of the year Award. Deadline for nominations is 14 January 2019.

read more

Bart Kiemeney among most cited researchers

13 December 2018

Bart Kiemeney made it to this year’s list of highly cited researchers. Researchers in this list are selected for their exceptional research performance and are regarded to have had a major impact on fellow scientists.

read more

Metal surgical implants can activate drugs

13 December 2018

Marja Bulte-ter Meer and Leo Schultze Kool discovered that the iron in metal surgical implants can activate drugs such as antibiotics, thus enabling targeted therapy.

read more

A personal touch of Dimitri Diavatopoulos

13 December 2018

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Dimitri Diavatopoulos.

read more

Annual CaRe days 8 & 9 May 2019

13 December 2018

The CaRe days provides an inspiring program for all RIHS researchers. Save the date!

read more
  • Go to